Načítá se...
Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer’s disease
OBJECTIVE: This study was mainly conducted to explore the expression changes of GSDMD and conventional markers (including T‐Tau, Tau181p, and Aβ(1–42)) in the cerebrospinal fluid among patients with Alzheimer's disease (AD) and vascular dementia (VD), followed by determination of role of GSDMD...
Uloženo v:
| Vydáno v: | Brain Behav |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035446/ https://ncbi.nlm.nih.gov/pubmed/33587329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.2063 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|